Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · IEX Real-Time Price · USD
1.080
+0.060 (5.88%)
At close: Jul 2, 2024, 4:00 PM
1.100
+0.020 (1.85%)
After-hours: Jul 2, 2024, 7:57 PM EDT
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of $52.53 million as of July 2, 2024. Its market cap has decreased by -68.24% in one year.
Market Cap
52.53M
Enterprise Value
21.66M
1-Year Change
-68.24%
Ranking
Category
Stock Price
$1.08
Market Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has decreased from $193.50M to $52.53M, a decrease of -72.85%. That is a compound annual growth rate of -18.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 49.60M | -58.35% |
| Dec 29, 2023 | 119.10M | 18.15% |
| Dec 30, 2022 | 100.80M | -71.94% |
| Dec 31, 2021 | 359.20M | -5.17% |
| Dec 31, 2020 | 378.80M | 3.78% |
| Dec 31, 2019 | 365.00M | 285.84% |
| Dec 31, 2018 | 94.60M | -51.11% |
| Jan 2, 2018 | 193.50M | - |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InspireMD | 62.28M |
| Cryo-Cell International | 61.68M |
| Hyperfine | 61.21M |
| Personalis | 60.77M |
| Turnstone Biologics | 60.60M |
| Aileron Therapeutics | 59.80M |
| Nutriband | 59.59M |
| HOOKIPA Pharma | 57.14M |